Prognostic grading after complete resection for thymic malignancies

Area of Science:

• Oncology
• Thoracic Surgery
• Pathology

Background:

• Thymic malignancies are rare tumors with prognosis historically described by World Health Organization (WHO) histotypes and Masaoka staging.
• These classification systems have typically been used independently, potentially limiting their prognostic accuracy.
• A comprehensive evaluation of inter-relationships between clinical, surgical, and pathological variables is needed for improved prognostication.

Purpose of the Study:

• To evaluate the prognostic impact of combining WHO histotypes and Masaoka staging with surgical and pathological variables in completely resected thymic malignancies.
• To investigate the inter-relationships between these diverse prognostic factors.
• To develop a more accurate predictive model for long-term outcomes in thymic cancer patients.

Main Methods:

• Retrospective review of 305 patients with completely resected thymic malignancies over 40 years.
• Analysis of World Health Organization (WHO) histotypes and Masaoka stages.
• Cox regression analysis was employed to assess the prognostic significance of 13 surgical and pathological factors, including peri-thymic infiltration.

Main Results:

• Independently, WHO histotypes showed limited prognostic differentiation, but clustered into two distinct groups (A-AB-B1-B2 vs. B3-C) with significant differences in long-term survival (LTS) and disease-free survival (DFS).
• Masaoka staging remained a relevant prognostic factor, though differences between stages I vs. II and III vs. IV were not always distinct.
• Pathological infiltration of peri-thymic structures emerged as a critical factor, significantly impacting LTS and DFS (Cox-p < 0.001). Combining WHO malignancy clusters and infiltration clusters identified four classes with distinct prognostic significance.

Conclusions:

• The combination of pathological and surgical variables, alongside established classifications like WHO histotypes and Masaoka staging, significantly enhances prognosis predictability in thymic malignancies.
• This integrated approach provides a more accurate assessment of long-term outcomes for patients undergoing complete resection.
• Future risk stratification and treatment planning can benefit from this multi-factorial prognostic model.